Sun, 3 March 2013
Dr. Lecia Sequist: Can We Bring The Advances in Targeted Therapy to Squamous NSCLC and Broader NSCLC Populations?
Dr. Lecia Sequist provides her thoughts on how molecular oncology can soon begin affecting treatment plans for a broader range of patients with lung cancer, including those with squamous NSCLC and other lung cancer histologies.
Direct download: GRACEcastUC-040_Lung-Video_Sequist_on_Broad_Use_of_Molec_Oncol.m4v
Category:Lung-Cancer-Video -- posted at: 8:28pm PDT